Last month, Actionable Intelligence reported on a class-action lawsuit filed against Eastman Kodak alleging securities fraud surrounding the company’s announcement of a $765 million government loan intended to help the company develop pharmaceutical ingredients for fighting COVID-19 (see “Kodak Named in Securities Class Action over Issues Surrounding $765M Government Loan”). On August 26, a second
